The NHS spends at least £750 million on “fat jabs” (weight-loss injections), according to figures reported by the outlets. The reporting also says spending on Mounjaro increases sharply, with outlays tripling in 2025.
The articles compare this level of spending with the funding available to the Cancer Drugs Fund, describing the weight-loss drug total as more than twice the Cancer Drugs Fund allocation. While the outlets focus on the scale of expenditure and the growth in demand for Mounjaro, they also cite the relative size of funding for cancer treatment access.
Overall, both sources draw on the same general set of figures: total weight-loss injection spending is at least £750 million and Mounjaro-related spending rises markedly in 2025, with attention drawn to how that compares to cancer-related budgets.
